Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V504 + Gardasil in young women
NCT00551187Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Oct 2007
- Primary completion
- May 2009
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of Human papillomavirus vaccine recombinant pentavalent in human papillomavirus infection, sponsored by Merck & Co.. Started Oct 2007; status: completed.
02
Drugs
Human papillomavirus vaccine recombinant pentavalent
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT00551187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00551187.